← Back to all trials
Recruiting
NCT05733091
Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors
Conditions: Tumors
Sex: All
Ages: 18 Years – N/A
Enrollment: 300
Sponsor: M.D. Anderson Cancer Center
Location: United States
Summary
To learn about the symptoms and changes our patients experience while receiving treatment for sinonasal or nasopharyngeal cancer
Eligibility Criteria
Inclusion criteria:Previously untreated patients with or suspected to have sinonasal malignancy or nasopharyngeal malignancy diagnosis based on either outside pathology report or MD Anderson pathology report.Age ≥ 18 yearsPlan to obtain the majority of treatment at MDACC including surgery and radiotherapyAbility to understand and willingness to sign written informed consentExclusion criteria:History of the previous solid or liquid malignancies, apart from skin cancers treated with local therapy.Existing neurocognitive impairment that is not the result of sinonasal and nasopharyngeal cancers or is treatment.Previous treatment for sinonasal or nasopharyngeal carcinomas, apart from biopsy.
Source: ClinicalTrials.gov (NCT05733091). StuddyBuddy aggregates publicly available trial information.